Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Study of the Usefulness of the Artery First Approach in Pancreatic Cancer With Pancreaticoduodenectomy

NCT04136522 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT04136522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04136522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Study of the Usefulness of the Artery First Approach in Pancreatic Cancer With Pancreaticoduodenectomy
Lead sponsor
Asan Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
January 10, 2020
Completion date
December 31, 2023
Enrollment
268 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

margin, tumor-free, pancreatic cancer, adult, recurrence tumor, surgery site fistula